High Intensity Focused Ultrasound in Prostate Cancer - Trial NCT06402357
Access comprehensive clinical trial information for NCT06402357 through Pure Global AI's free database. This Phase 2 trial is sponsored by University of Florida and is currently Not yet recruiting. The study focuses on Prostate Cancer. Target enrollment is 25 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Florida
Timeline & Enrollment
Phase 2
Aug 01, 2024
Aug 01, 2029
Primary Outcome
In-field failure-free survival
Summary
This study will investigate the efficacy of focal high intensity focused ultrasound (HIFU) in
 patients with localized radiorecurrent prostate cancer. This study will also investigate the
 change in participant quality of life after HIFU therapy as compared to before HIFU therapy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06402357
Device Trial